AMVUTTRA
Live / Registered — Registered (as of 06 Sept 2022)
What this means for you
Registered since 06 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90151672
- Registration number
- 6840129
- Mark type
- Stylized text
- Filed
- 01 Sept 2020
- Published for opposition
- 02 Feb 2021
- Registered
- 06 Sept 2022
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of amyloidosis
Owner
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 06 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 04 Aug 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Aug 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Aug 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Jul 2022 — USE AMENDMENT FILED
- 01 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Jul 2022 — TEAS STATEMENT OF USE RECEIVED
- 15 Jul 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Jul 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 15 Jul 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Jul 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Feb 2022 — SOU EXTENSION 2 GRANTED
- 18 Feb 2022 — SOU EXTENSION 2 FILED